For instance, pharmacologically inhibiting specific UPR pathways, such as IRE1α-XBP1, could reverse tumor-intrinsic immune evasion by restoring the expression of MHC-I and MICA, thereby enhancing tumor cell recognition by CD8+ T cells and NK cells, respectively214. Here, XBP1 is linked to neoplasm.